Genesco (GCO) Posts Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Genesco (NYSE:GCO) posted its quarterly earnings results on Thursday. The company reported $0.95 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.86 by $0.09, RTT News reports. Genesco had a positive return on equity of 7.53% and a negative net margin of 3.77%. The business had revenue of $713.10 million for the quarter, compared to analyst estimates of $712.06 million. During the same period last year, the company earned $1.02 EPS. The firm’s revenue was down .5% on a year-over-year basis. Genesco updated its FY 2019 guidance to $3.10-3.40 EPS and its FY19 guidance to $3.15-3.40 EPS.

Shares of Genesco stock opened at $42.91 on Thursday. The firm has a market cap of $866.47 million, a P/E ratio of 13.67, a price-to-earnings-growth ratio of 1.79 and a beta of 1.03. Genesco has a 12 month low of $27.20 and a 12 month high of $51.85. The company has a debt-to-equity ratio of 0.10, a quick ratio of 0.53 and a current ratio of 2.43.

Several research firms have recently issued reports on GCO. Zacks Investment Research lowered Genesco from a “hold” rating to a “sell” rating in a research report on Monday. Pivotal Research reaffirmed a “buy” rating and set a $52.00 price objective on shares of Genesco in a research note on Monday. Piper Jaffray Companies set a $41.00 price objective on Genesco and gave the stock a “hold” rating in a research note on Friday, November 30th. ValuEngine raised Genesco from a “hold” rating to a “buy” rating in a research note on Tuesday, November 27th. Finally, Macquarie raised their price objective on Genesco from $28.00 to $32.00 and gave the stock a “hold” rating in a research note on Monday, September 10th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. Genesco has a consensus rating of “Hold” and a consensus target price of $41.78.



Institutional investors have recently modified their holdings of the stock. Raymond James & Associates raised its stake in Genesco by 21.0% during the 2nd quarter. Raymond James & Associates now owns 29,480 shares of the company’s stock worth $1,170,000 after buying an additional 5,126 shares during the period. AMP Capital Investors Ltd acquired a new stake in shares of Genesco in the 2nd quarter valued at about $292,000. Fox Run Management L.L.C. acquired a new stake in shares of Genesco in the 3rd quarter valued at about $467,000. Carillon Tower Advisers Inc. raised its stake in shares of Genesco by 1.3% in the 2nd quarter. Carillon Tower Advisers Inc. now owns 1,321,749 shares of the company’s stock valued at $52,473,000 after purchasing an additional 17,469 shares during the period. Finally, Valeo Financial Advisors LLC acquired a new stake in shares of Genesco in the 2nd quarter valued at about $1,625,000.

WARNING: “Genesco (GCO) Posts Quarterly Earnings Results, Beats Estimates By $0.09 EPS” was posted by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://dakotafinancialnews.com/2018/12/06/genesco-gco-posts-quarterly-earnings-results-beats-estimates-by-0-09-eps.html.

Genesco Company Profile

Genesco Inc retails and wholesales footwear, apparel, and accessories. The company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group, and Licensed Brands. The Journeys Group segment offers footwear and accessories through the Journeys, Journeys Kidz, Shi by Journeys, and Little Burgundy retail chains, as well as through e-commerce and catalogs for young men, women, and children.

Further Reading: Can individual investors take part in an IPO?

Earnings History for Genesco (NYSE:GCO)

Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply